Tag: study

Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”).

NYU IHIF 2026 Takes Place May 31-June 2 at the Marriott Marquis in New York

Toronto, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- In a significant step toward mainstreaming crypto-based passive income, Coinchange and Kanga Exchange have joined forces to offer automated yield solutions—resulting in over 30% user adoption in just months. The partnership between Coinchange, a digital asset management platform, and Kanga Exchange, a leading cryptocurrency exchange platform, demonstrates how the integration of yield-generating solutions can simplify access to passive income opportunities. The collaboration has enabled over 30% of Kanga’s active users to generate passive income through multi-strategy active portfolio management solutions on their digital asset holdings without requiring active supervision or technical expertise.

- AGA2115 also received Orphan Drug Designation from European Medicines Agency